Recombinant PCSK9 (Alirocumab Biosimilar) antibody

Catalog No. ABIN7487990

This Mammalian Cells Monoclonal antibody specifically detects PCSK9 (Alirocumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant PCSK9 (Alirocumab Biosimilar) antibody (ABIN7487990)

Target: PCSK9 (Alirocumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This PCSK9 (Alirocumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-PCSK9 (Alirocumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Alirocumab Biosimilar - Anti-PCSK9 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for PCSK9 (Alirocumab Biosimilar)

Target: PCSK9 (Alirocumab Biosimilar)

Target Type: Biosimilar

Background: REGN727,SAR-236553
Alirocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia.

CAS-No: 1245916-14-6